Resource Library

COVID-19 severity and vaccine effectiveness in the era of the Omicron variant. – Annex

COVID-19 severity and vaccine effectiveness in the era of the Omicron variant. 

What do we know about the Novavax vaccine?

The glut of COVID-19 vaccines is a myth: How we can — and must — remove barriers to vaccinating the world against COVID-19

Update: Opening K-12 schools for in-person learning amidst vaccines and variants: what have we learned and how can this guide us?

Protecting the Immunocompromised: The Evidence for an Additional Dose of COVID-19 Vaccine.

A Hidden Toll: The Mental Health Impacts of COVID-19 on the Public Health Workforce.

Opening K-12 schools for in-person learning amidst vaccines and variants: what have we learned and how can this guide us?

In it for the Long Haul: More Questions than Answers on the Lasting Health Effects of COVID-19

How genomic surveillance helps us understand SARS-CoV-2

The latest on COVID-19 treatments: evidence, approvals, guidelines and the implications of new variants.

In depth: Should second doses of COVID-19 vaccines be delayed?

Should everyone wear medical masks to prevent the spread of COVID-19?

Early COVID-19 vaccination rollout top performers

A national COVID-19 alert level framework

Immunity Passports